Your session is about to expire
← Back to Search
Other
Laser Therapy for Scarring
N/A
Waitlist Available
Led By Keyvan Nouri, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients should have mild to severe post-surgical scarring located on head and neck
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 13 weeks
Awards & highlights
Study Summary
This trial is testing a laser to see if it can improve the appearance of surgical scars.
Who is the study for?
This trial is for adults over 18 with scars at least 3 cm long on the head or neck, who can consent to participate. It's not for those under other scar treatments, pregnant or breastfeeding women, people with very dark skin (Fitzpatrick V-VI), connective tissue diseases like scleroderma, photosensitivity issues, or recent cosmetic procedures.Check my eligibility
What is being tested?
The study tests how well a specific laser treatment (2940 nm Er:YAG) improves surgical scars by using optical coherence tomography imaging. This non-invasive technique provides detailed images of the scar tissue before and after treatment.See study design
What are the potential side effects?
Potential side effects from the Er:YAG laser may include temporary redness, swelling at the treated area, changes in skin coloration, discomfort during treatment, and rare cases of scarring from the procedure itself.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have mild to severe scarring on my head or neck from surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 13 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 13 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
POSAS Scar Assessment
Surgical Scar Blood Flow
Surgical Scar Collagen Content
+2 moreSecondary outcome measures
Incidence of Adverse Events
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Er:YAG laser GroupExperimental Treatment1 Intervention
The study is a split-scar model. Participants will have half of their lesion receive a total of three sessions using 2940 nm Er:YAG laser spaced over a 4-week study participation interval.
Group II: Control (No Intervention) GroupActive Control1 Intervention
The study is a split-scar model. Participants will serve as their own control and have half of their lesion receive no intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Er:YAG laser
2014
N/A
~400
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
899 Previous Clinical Trials
409,732 Total Patients Enrolled
3 Trials studying Scarring
47 Patients Enrolled for Scarring
Keyvan Nouri, MDPrincipal InvestigatorUniversity of Miami
8 Previous Clinical Trials
107 Total Patients Enrolled
2 Trials studying Scarring
38 Patients Enrolled for Scarring
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have scleroderma.I am 18 years old or older.I have mild to severe scarring on my head or neck from surgery.My scar is smaller than 3 cm.I am not using any treatments for my scars during the study.I haven't had facial treatments like Botox, peels, or used oral retinoids in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Er:YAG laser Group
- Group 2: Control (No Intervention) Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this trial open at present?
"This research is not currently enrolling patients, as per the information on clinicaltrials.gov which was last edited on November 3rd 2022. Although this trial is paused for now, there are 49 other medical studies actively recruiting participants at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger